If picking up from our office, please bring a small cooler with an ice pack
Based on clinical trial results, some individuals may see an improvement in glucose control as measured by A1c within the first 4 weeks, which can correlate with weight loss, but individual results can vary
Researchers found that GLP-1 agonists used for weight loss were associated with increased risks of pancreatitis, gastroparesis, and bowel obstruction compared with bupropion-naltrexone, although that study should be understood as observational rather than definitive proof of causation
Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist typically delivered through an injection
This article is specifically about GLP-1 foods
Quick Answer: The SUSTAIN trial program didnt list increased urination as a primary adverse event Ozempic doesnt act on the kidney directly